| A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain (NCT05419076) | Memorial Sloan Kettering Cancer Center | 2022-06-10 |
| Pembro+Chemo in Brain Mets (NCT04964960) | John L. Villano, MD, PhD | 2022-05-19 |
| DBT for Metastatic Lung Cancer (NCT04973436) | Duke University | 2022-05-18 |
| A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC (NCT05144529) | Eziafa Oduah, MD, PhD, MPH | 2022-03-22 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System (NCT06722885) | Universitair Ziekenhuis Brussel | 2022-01-01 |
| Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer (NCT04405401) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-01-05 |
| NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer (NCT04986670) | Tufts University | 2020-11-24 |
| Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment (NCT04440800) | Royal Marsden NHS Foundation Trust | 2020-07-01 |
| Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer (NCT04311762) | University of Vermont | 2020-02-01 |
| Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer (NCT04085315) | Collin Blakely | 2019-11-12 |
| Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC (NCT04069936) | WindMIL Therapeutics | 2019-10-15 |
| Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC (NCT03706287) | Sichuan Cancer Hospital and Research Institute | 2018-12-06 |
| A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib. (NCT03755102) | Memorial Sloan Kettering Cancer Center | 2018-11-21 |
| PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities (NCT03693326) | Asan Medical Center | 2018-11-01 |
| Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer (NCT03638765) | Northwest Biotherapeutics | 2018-11-01 |
| Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation (NCT03693339) | Asan Medical Center | 2018-10-30 |
| Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC (NCT03703596) | Sichuan Cancer Hospital and Research Institute | 2018-10-16 |
| Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation (NCT03543306) | Asan Medical Center | 2018-06-30 |
| ANET Electrosurgery Applicator Pilot Evaluation Study (NCT03400748) | Olympus Corporation of the Americas | 2018-04-23 |
| Needlescopic-assisted Uniportal vs Uniportal VATS (NCT03439696) | IRB of NTUH Hsin-Chu Branch | 2018-02-22 |
| Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy (NCT03595813) | Institut Paoli-Calmettes | 2018-01-29 |
| Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors (NCT03272971) | Broncus Medical Inc | 2017-12-05 |
| Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT03184571) | BerGenBio ASA | 2017-10-02 |
| Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer (NCT03113851) | Peking University Cancer Hospital & Institute | 2017-08-14 |
| Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC (NCT03057106) | Canadian Cancer Trials Group | 2017-03-28 |
| A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib (NCT03076164) | Memorial Sloan Kettering Cancer Center | 2017-03-01 |
| SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy (NCT02976740) | The First Affiliated Hospital of Xiamen University | 2016-11-01 |
| Neck Ultrasound by Respiratory Physicians in Patients With Lung Cancer (NCT03970564) | University College Hospital Galway | 2016-10-21 |
| Clinical Validation of the M5L Lung CAD (NCT03179150) | Candiolo Cancer Institute - IRCCS | 2015-09-01 |
| Early Palliative Care in Metastatic Lung Cancer in Northern France (NCT02308865) | University Hospital, Lille | 2014-10-17 |